TerrAscend Valuation Multiples

Discover TerrAscend's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Aurora Cannabis, Cannara Biotech, Organigram Global, High Tide and more.

TerrAscend Overview

About TerrAscend

TerrAscend Corp is a company focused on creating and delivering quality cannabis products and services that meet the evolving needs of its patients. It also provides education and support programs to physicians and patients through healthcare professionals. In addition, the Company has retail operations in Ontario, Canada, with a majority-owned dispensary in Toronto, Ontario, Canada. It has one operating segment, being the cultivation, production, and sale of cannabis products, with subsidiaries located in Canada and the United States.


Founded

2017

HQ

Canada

Employees

1.2K

Financials (LTM)

Revenue: $263M
EBITDA: $69M

EV

$365M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

TerrAscend Financials

TerrAscend reported last 12-month revenue of $263M and EBITDA of $69M.

In the same LTM period, TerrAscend generated $138M in gross profit, $69M in EBITDA, and had net loss of ($46M).

Revenue (LTM)


TerrAscend P&L

In the most recent fiscal year, TerrAscend reported revenue of $261M and EBITDA of $68M.

TerrAscend is unprofitable as of last fiscal year, with gross margin of 52%, EBITDA margin of 26%, and net margin of (31%).

See analyst estimates for TerrAscend
LTMLast FY202320242025202620272028
Revenue$263M$261M$317M$307M$261M
Gross Profit$138M$136M$160M$150M$136M
Gross Margin52%52%50%49%52%
EBITDA$69M$68M($1M)$6M$58M
EBITDA Margin26%26%(0%)2%22%
EBIT Margin16%17%11%8%17%
Net Profit($46M)($81M)($91M)($80M)($86M)
Net Margin(17%)(31%)(29%)(26%)(33%)
Net Debt-$189M---

Financial data powered by Morningstar, Inc.

TerrAscend Stock Performance

TerrAscend has current market cap of $151M, and enterprise value of $365M.

Market Cap Evolution


TerrAscend's stock price is $0.49.

TerrAscend share price decreased by 27.8% in the last 30 days, and increased by 20.6% in the last year.

TerrAscend has an EPS (earnings per share) of $-0.26.

See more trading valuation data for TerrAscend
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$365M$151M-7.0%-27.8%-35.7%20.6%$-0.26

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

TerrAscend Valuation Multiples

TerrAscend trades at 1.4x EV/Revenue multiple, and 5.3x EV/EBITDA.

See NTM and 2027E valuation multiples for TerrAscend

EV / Revenue (LTM)


TerrAscend Financial Valuation Multiples

As of July 29, 2026, TerrAscend has market cap of $151M and EV of $365M.

TerrAscend has a P/E ratio of (3.3x).

LTMLast FY202320242025202620272028
EV/Revenue1.4x1.4x1.2x1.2x1.4x
EV/EBITDA5.3x5.4xn/m59.3x6.2x
EV/EBIT8.4x8.2x10.4x14.7x8.2x
EV/Gross Profit2.6x2.7x2.3x2.4x2.7x
P/E(3.3x)(1.9x)(1.7x)(1.9x)(1.8x)
EV/FCF22.8x28.2x20.2x13.3x30.0x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified TerrAscend Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

TerrAscend Margins & Growth Rates

TerrAscend grew revenue by 2% and EBITDA by 2% in the last fiscal year.

In the most recent fiscal year, TerrAscend reported gross margin of 52%, EBITDA margin of 26%, and net margin of (31%).

See estimated margins and future growth rates for TerrAscend

TerrAscend Margins

Last FY202420252026202720282029
Gross Margin52%49%52%52%
EBITDA Margin26%2%22%26%
EBIT Margin17%8%17%16%
Net Margin(31%)(26%)(33%)(8%)
FCF Margin5%9%5%7%

TerrAscend Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth2%(3%)(15%)2%
Gross Profit Growth2%(6%)(9%)2%
EBITDA Growth2%(700%)850%19%
EBIT Growth(4%)(29%)80%(4%)
Net Profit Growth(75%)(12%)7%(77%)
FCF Growth41%52%(56%)50%

Data powered by FactSet, Inc. and Morningstar, Inc.

TerrAscend Operational KPIs

TerrAscend's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

TerrAscend's Rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

TerrAscend's Rule of X is 31% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for TerrAscend
LTMLast FY202320242025202620272028
Rule of 4030%28%---
Bessemer Rule of X37%31%---
Revenue per Employee-$0.2M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue-2%3%2%2%
G&A Expenses to Revenue31%31%32%34%30%
Opex to Revenue-35%39%41%35%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

TerrAscend Competitors

TerrAscend competitors include Aurora Cannabis, Cannara Biotech, Organigram Global, High Tide, Grown Rogue International, Ispire Technology, Ascend Wellness Holdings, Jushi Holdings, Cresco Labs and Planet 13.

Most TerrAscend public comparables operate across Cannabis, CannaTech and ViceTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Aurora Cannabis0.4x0.5x2.7x3.4x
Cannara Biotech1.9x1.7x7.1x6.4x
Organigram Global0.7x0.6x9.8x8.5x
High Tide0.6x0.5x9.4x7.3x
Grown Rogue International3.4x-12.1x-
Ispire Technology0.6x0.9x(2.4x)8.3x
Ascend Wellness Holdings1.3x1.3x5.6x5.8x
Jushi Holdings1.3x1.3x6.8x6.8x

This data is available for Pro users. Sign up to see all TerrAscend competitors and their valuation data.

Start Free Trial

Acquisitions by TerrAscend

TerrAscend has acquired 8 companies to date.

Last acquisition by TerrAscend was on November 6th 2024. TerrAscend acquired Ratio Cannabis for $10M (EV/Revenue multiple available to Pro users).

See M&A valuation multiples

Latest Acquisitions by TerrAscend

Ratio Cannabis
Pinnacle
Allegany Medical Marijuana Dispensary
Gage Cannabis
Description
Ratio Cannabis is a medical marijuana dispensary operating in Ohio. Located in Columbus, it dispenses cannabis flower, edibles, tinctures, and topicals approved by the Ohio Board of Pharmacy. Ratio emphasizes patient education with on-site consultations and delivery services in select areas. The dispensary sources products from licensed cultivators like PharmaCann. Opened in 2021, it complies with Ohio's Medical Marijuana Control Program regulations.
Pinnacle is a Denver-based provider of medical cannabis products including full-spectrum tinctures, vape cartridges, and edibles formulated with organic terpenes. The company dispenses at its Colorado dispensaries and ships flower strains like Pinnacle Purple Kush grown in Pueblo County greenhouses. Products undergo third-party testing for 100+ cannabinoids via Steep Hill Labs. Licensed since 2014, Pinnacle supplies 20 retail locations statewide.
Allegany Medical Marijuana Dispensary is a licensed provider in Cumberland, Maryland promoting cannabis as part of healthy lifestyles. Offers medical marijuana products including flower, tinctures, and edibles formulated for dietary integration. Educates patients on strains for wellness benefits like pain relief and appetite stimulation.
Gage Cannabis Co. is a vertically integrated cannabis operator in Michigan with cultivation facilities in St. Clair and Armada, processing centers, and 23 retail dispensaries statewide including Detroit and Ferndale. Founded in 2019 and headquartered in East Lansing, it distributes products from global brands such as Cookies, Runtz, and STIIIZY through Gage-branded stores and wholesale channels.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
New Philadelphia, OH
Morenci, MI
Cumberland, MD
Detroit, MI
Deal Date6 Nov 202414 Apr 202211 Apr 20221 Sep 2021
Valuation$10M$29M$12M$545M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all TerrAscend acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About TerrAscend

When was TerrAscend founded?TerrAscend was founded in 2017.
Where is TerrAscend headquartered?TerrAscend is headquartered in Canada.
How many employees does TerrAscend have?As of today, TerrAscend has over 1K employees.
Who is the CEO of TerrAscend?TerrAscend's CEO is Ziad Ghanem.
Is TerrAscend publicly listed?Yes, TerrAscend is a public company listed on OTCM.
What is the stock symbol of TerrAscend?TerrAscend trades under TSNDF ticker.
When did TerrAscend go public?TerrAscend went public in 2017.
Who are competitors of TerrAscend?TerrAscend main competitors include Aurora Cannabis, Cannara Biotech, Organigram Global, High Tide, Grown Rogue International, Ispire Technology, Ascend Wellness Holdings, Jushi Holdings, Cresco Labs, Planet 13.
What is the current market cap of TerrAscend?TerrAscend's current market cap is $151M.
What is the current revenue of TerrAscend?TerrAscend's last 12 months revenue is $263M.
What is the current revenue growth of TerrAscend?TerrAscend revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of TerrAscend?Current revenue multiple of TerrAscend is 1.4x.
What is the current EBITDA of TerrAscend?TerrAscend's last 12 months EBITDA is $69M.
What is TerrAscend's EBITDA margin?TerrAscend's last 12 months EBITDA margin is 26%.
What is the current EV/EBITDA multiple of TerrAscend?Current EBITDA multiple of TerrAscend is 5.3x.
What is the current FCF of TerrAscend?TerrAscend's last 12 months FCF is $16M.
What is TerrAscend's FCF margin?TerrAscend's last 12 months FCF margin is 6%.
What is the current EV/FCF multiple of TerrAscend?Current FCF multiple of TerrAscend is 22.8x.
How many companies TerrAscend has acquired to date?As of July 2026, TerrAscend has acquired 8 companies.
What was the largest acquisition by TerrAscend?$545M acquisition of Gage Cannabis on 1st September 2021 was the largest M&A TerrAscend has done to date.
What companies TerrAscend acquired?TerrAscend acquired Gage Cannabis, Ilera Healthcare, The Apothecarium, Keystone Canna Remedies, Pinnacle, HMS Health, Allegany Medical Marijuana Dispensary, and Ratio Cannabis.
In how many companies TerrAscend has invested to date?TerrAscend hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to TerrAscend

Lists including TerrAscend

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial